Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

HEAT-Net 2021

06–08 September 2021 | Göttingen, Germany

HEAT-Net 2021

06–08 September 2021 | Göttingen, Germany
CRISPR-Cas9 in vivo gene editing: a new frontier 1:58
CRISPR-Cas9 in vivo gene editing: a new frontier
Martin Ingelsson • 21 Sep 2021
sGFAP: a potential diagnostic and prognostic marker in FTD 2:21
sGFAP: a potential diagnostic and prognostic marker in FTD
Annakaisa Haapasalo • 16 Sep 2021
The need for improved prognostic markers in Alzheimer’s disease 1:02
The need for improved prognostic markers in Alzheimer’s disease
Alberto Lleó • 1 Sep 2021
What’s to come in FTD? Important avenues and key research themes 1:57
What’s to come in FTD? Important avenues and key research themes
Annakaisa Haapasalo • 16 Sep 2021
How does C9orf72 expansion impact protein degradation pathways in FTLD and ALS? 4:02
How does C9orf72 expansion impact protein degradation pathways in FTLD and ALS?
Annakaisa Haapasalo • 16 Sep 2021
VAMP-2 as a CSF marker of cognitive decline in Alzheimer’s disease 2:19
VAMP-2 as a CSF marker of cognitive decline in Alzheimer’s disease
Alberto Lleó • 1 Sep 2021
CRISPR–Cas9 gene therapy for neurodegenerative diseases 4:05
CRISPR–Cas9 gene therapy for neurodegenerative diseases
Martin Ingelsson • 21 Sep 2021
A novel genetic marker to detect C9orf72 repeat expansion carriers 3:43
A novel genetic marker to detect C9orf72 repeat expansion carriers
Annakaisa Haapasalo • 16 Sep 2021
A novel method for detection of early oligomeric α-synuclein pathology 5:03
A novel method for detection of early oligomeric α-synuclein pathology
Anish Behere • 9 Sep 2021
Alpha-synuclein pathology: dangerous mitochondrial interactions 1:57
Alpha-synuclein pathology: dangerous mitochondrial interactions
Tiago Outeiro • 31 Aug 2021
CSF biomarkers for the early diagnosis of Alzheimer’s disease 2:41
CSF biomarkers for the early diagnosis of Alzheimer’s disease
Alberto Lleó • 1 Sep 2021
CSF biomarkers versus blood biomarkers for the early diagnosis of Alzheimer’s disease 0:50
CSF biomarkers versus blood biomarkers for the early diagnosis of Alzheimer’s disease
Alberto Lleó • 1 Sep 2021
HEAT-Net 2021 – Frontiers in neurodegeneration: what’s to come? 3:27
HEAT-Net 2021 – Frontiers in neurodegeneration: what’s to come?
Tiago Outeiro • 31 Aug 2021
What will be discussed at HEAT-Net 2021? 1:24
What will be discussed at HEAT-Net 2021?
Tiago Outeiro • 31 Aug 2021
The content of VJNeurology is intended for healthcare professionals